Nature's Sunshine Products Inc. (United States) is listed on the Nasdaq and has a market capitalization of $464.78 Millions, with shareholders equity totaling $161.55 Millions.
The company employs approximately 837 people and operates in the Health Care sector, within the Biotechnology industry.
Over the past 12 months, Nature's Sunshine Products Inc. reported $480.15 Millions in revenue, generating net income of $19.52 Millions.
Key financial metrics include a P/E ratio of 23.81, a price-to-book (P/B) ratio of 2.88, and a trailing twelve-month dividend yield of 0.00%.
The company trades under the ticker NATR.